Related Experiment Video
Updated: Jun 10, 2026
09:52
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
Novel gene associations in type 1 diabetes
1Immunogenetics Laboratory, University of Turku, Tykistökatu 6A, Turku, Finland. jsilonen@utu.fi
Current Diabetes Reports
|July 21, 2010
Summary
Genome-wide studies reveal numerous type 1 diabetes (T1D) susceptibility genes, but the HLA region remains key. Understanding the complex autoimmune mechanisms driving T1D pathogenesis requires further investigation into these genetic factors.
Area of Science:
- Immunogenetics
- Autoimmune Diseases
- Genetic Epidemiology
Background:
- Genome-wide association studies (GWAS) have identified multiple gene loci associated with type 1 diabetes (T1D) susceptibility.
- The impact of newly identified loci appears to diminish with their increasing number.
- The Human Leukocyte Antigen (HLA) gene region continues to be the primary determinant of genetic susceptibility to T1D.
Purpose of the Study:
- To highlight the diminishing impact of newly identified T1D susceptibility loci.
- To emphasize the predominant role of the HLA gene region in T1D genetic susceptibility.
- To underscore the need for further research into the specific genes and mechanisms within the HLA region and other risk loci.
Main Methods:
- Review of recent genome-wide association studies (GWAS) in type 1 diabetes.
- Analysis of the relative contributions of identified genetic loci to T1D susceptibility.
- Examination of the known functions of T1D risk gene products in immune system regulation.
Main Results:
- While numerous T1D susceptibility loci have been identified, their individual impact is decreasing.
- The HLA gene region remains the most significant contributor to T1D genetic predisposition.
- The precise genes and mechanisms underlying HLA-associated T1D risk are still largely undetermined.
Conclusions:
- The genetic architecture of type 1 diabetes is complex, involving multiple genes.
- The HLA region plays a critical, though not fully understood, role in T1D pathogenesis.
- Further research is crucial to elucidate the functional mechanisms of T1D risk genes and their role in immune dysregulation leading to autoimmunity.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...